Menu Close

A federal grand jury in Boston has indicted a 33-year-old Georgian national on a single count of conspiracy to launder money, in a case federal prosecutors say is tied to the largest health care fraud scheme the Department of Justice has ever prosecuted.

The U.S. Department of Justice announced that Erekle Gugava was charged in the District of Massachusetts in connection with Operation Gold Rush, the government’s name for its investigation into a transnational fraud and money-laundering network that DOJ says targeted Medicare and other health insurers. According to a companion release from the U.S. Attorney’s Office for the District of Massachusetts, Gugava fled the United States in July 2025, after the conduct alleged in the indictment.

Gugava served as a money launderer for a criminal organization based in Russia and elsewhere that prosecutors describe as responsible for the largest health care fraud case the department has ever brought. Gugava is alleged to have owned ND Medical Solutions LLC, a durable medical equipment supplier based in Pennsylvania, between February and July 2025. During that roughly five-month period, ND Medical is alleged to have submitted at least $1.3 billion in fraudulent equipment claims to Medicare, to private insurers that sell Medicare supplemental coverage, to employer-sponsored health plans, and to other insurers. DOJ states that insurers actually paid out approximately $6.5 million on those claims before the scheme was uncovered — a gap the department attributes to the claims being caught before most of the billed amount was paid.

The fraudulent billings relied in part on stolen identities of Medicare beneficiaries, including elderly and disabled Americans across New England and elsewhere in the country, some of whom reported concerns to Medicare after receiving explanation-of-benefit notices for equipment they say they never received, prescribed by doctors they say they never saw. Prosecutors allege Gugava opened several bank accounts in ND Medical’s name, was the sole signatory on those accounts, deposited insurance reimbursement checks into them, and then moved the funds to overseas accounts for the benefit of the broader organization. DOJ’s release notes that health care fraud proceeds are especially attractive to launderers because they originate from legitimate payors — Medicare and established private carriers — which gives the funds an initial appearance of legitimacy.

Assistant Attorney General Colin M. McDonald of DOJ’s National Fraud Enforcement Division was quoted in the department’s release saying deterring “facilitators is essential to safeguarding taxpayer resources,” and that the indictment reflects the department’s “resolve to hold all participants in fraud networks accountable.” Those are characterizations from a DOJ official, not adjudicated findings, and the indictment itself remains only an accusation — DOJ’s own release states that Gugava is presumed innocent unless and until the government proves the charge beyond a reasonable doubt.

Gugava is charged with one count of conspiracy to commit money laundering and faces a maximum of 20 years in prison if convicted. The case was announced jointly by the National Fraud Enforcement Division, the U.S. Attorney’s Office for Massachusetts, and investigators from HHS’s Office of Inspector General, the FBI, the U.S. Postal Inspection Service, IRS Criminal Investigation, Homeland Security Investigations, and the Department of Labor’s Employee Benefits Security Administration. DOJ’s release places the case in the context of its Health Care Fraud Strike Force Program, which it says has charged more than 6,200 defendants tied to over $45 billion in claims billed to federal health programs and private insurers since 2007, and notes that its fraud-enforcement work supports the White House’s Task Force to Eliminate Fraud, chaired by Vice President J.D. Vance.

For employers and insurers, the case is a reminder that durable medical equipment billing — an area with comparatively light utilization review compared to other claim types — remains a favored vector for large-scale, organized fraud rings, and that fraudulent claims can flow not just to Medicare but directly into employer-sponsored plans and Medicare supplemental products. Claims and special-investigations units may want to revisit DME billing controls and identity-verification protocols for beneficiaries in light of the pattern DOJ describes.